Danaher Co. (NYSE:DHR) insider Rainer Blair sold 3,981 shares of the stock in a transaction on Monday, February 26th. The stock was sold at an average price of $100.05, for a total value of $398,299.05. Following the completion of the transaction, the insider now owns 49,751 shares of the company’s stock, valued at approximately $4,977,587.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Rainer Blair also recently made the following trade(s):
- On Wednesday, February 21st, Rainer Blair sold 51,080 shares of Danaher stock. The stock was sold at an average price of $97.26, for a total value of $4,968,040.80.
Danaher Co. (NYSE:DHR) traded down $0.62 during trading on Wednesday, reaching $102.18. The company’s stock had a trading volume of 1,497,734 shares, compared to its average volume of 2,661,686. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.43 and a quick ratio of 1.05. The firm has a market capitalization of $71,330.00, a price-to-earnings ratio of 29.19, a price-to-earnings-growth ratio of 2.17 and a beta of 1.04. Danaher Co. has a 12 month low of $78.97 and a 12 month high of $104.82.
Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. The business had revenue of $5.09 billion for the quarter, compared to analyst estimates of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The business’s revenue for the quarter was up 10.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.05 earnings per share. equities research analysts anticipate that Danaher Co. will post 4.37 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Thursday, March 29th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.63%. This is a positive change from Danaher’s previous quarterly dividend of $0.14. Danaher’s dividend payout ratio (DPR) is presently 16.00%.
Institutional investors and hedge funds have recently bought and sold shares of the stock. Honeywell International Inc. boosted its stake in shares of Danaher by 113.4% during the third quarter. Honeywell International Inc. now owns 640,100 shares of the conglomerate’s stock valued at $54,908,000 after acquiring an additional 340,100 shares during the last quarter. Progressive Investment Management Corp lifted its position in Danaher by 5.9% during the fourth quarter. Progressive Investment Management Corp now owns 37,108 shares of the conglomerate’s stock worth $3,444,000 after buying an additional 2,074 shares during the period. Hikari Tsushin Inc. lifted its position in Danaher by 8.9% during the second quarter. Hikari Tsushin Inc. now owns 65,135 shares of the conglomerate’s stock worth $5,497,000 after buying an additional 5,300 shares during the period. Prudential Financial Inc. lifted its position in Danaher by 5.2% during the third quarter. Prudential Financial Inc. now owns 2,628,584 shares of the conglomerate’s stock worth $225,480,000 after buying an additional 130,621 shares during the period. Finally, Point72 Asset Management L.P. lifted its position in Danaher by 276.8% during the third quarter. Point72 Asset Management L.P. now owns 2,626,865 shares of the conglomerate’s stock worth $225,332,000 after buying an additional 1,929,751 shares during the period. 77.83% of the stock is currently owned by institutional investors and hedge funds.
DHR has been the subject of several research analyst reports. Stifel Nicolaus increased their price objective on Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Wednesday, January 31st. Cowen reiterated a “buy” rating and issued a $110.00 price objective on shares of Danaher in a research report on Tuesday, January 30th. UBS Group initiated coverage on Danaher in a research report on Monday, January 22nd. They issued a “buy” rating and a $99.97 price objective for the company. Robert W. Baird reiterated a “buy” rating on shares of Danaher in a research report on Friday, January 12th. Finally, Citigroup increased their price objective on Danaher to $107.00 and gave the stock a “buy” rating in a research report on Friday, December 15th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $101.40.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.